NCT01667198

Brief Summary

Professional societies recommend that endoscopists measure their ceacal intubation rate, adenoma detection rate as indicators of the screening colonoscopy quality. However, it is uncertain how to improve adenoma detection rate and reduce inter-endoscopists' variability in the detection of adenomas. The investigators hypothesize that a hands-on-training intervention tailored to the results of environmental assessment and audit on colonoscopy quality indicators results in higher adenoma detection rate improvement than simple audit and feedback. The investigators further hypothesize that by training the leaders of the screening centres, the effect of the intervention will be further disseminated among other endoscopists from the participating centers, and will thus result in additional increase in individual adenoma detection rate. The primary aim is to compare the impact on adenoma detection rate of two screening colonoscopy improvement programs:

  1. 1.Tailored training intervention.
  2. 2.Audit feedback on colonoscopy quality indicators.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at below P25 for not_applicable colorectal-cancer

Timeline
Completed

Started Jul 2012

Shorter than P25 for not_applicable colorectal-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 14, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 17, 2012

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

April 16, 2014

Status Verified

April 1, 2014

Enrollment Period

5 months

First QC Date

August 14, 2012

Last Update Submit

April 15, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Screening centre leader's adenoma detection rate

    Adenoma detection rate is defined as the proportion of screened subjects in whom at least one adenomatous lesion is identified.

    till the end of calendar year after the training intervention

Secondary Outcomes (5)

  • Screening center's overall adenoma detection rate

    Till the end of calendar year after the training intervention

  • Screening centre leader's proximal and distal adenoma detection rate

    Till the end of calendar year after the training intervention

  • Screening centre's non-polypoid lesion detection rate

    Till the end of calendar year after the training intervention

  • Overall screening centre's ceacal intubation rate

    Till the end of calendar year after the training intervention

  • Screening centre leader's withdrawal technique

    Till the end of calendar year after the training intervention

Study Arms (2)

Train the leaders course

EXPERIMENTAL
Procedure: Train the leaders course

Audit and feedback

ACTIVE COMPARATOR
Behavioral: Audit and feedback

Interventions

Screening centre leaders randomized to the training intervention group will be invited to take part in a train-the-leaders course. The Train-the-leaders course will consist of three phases: (i) pre-training assessment, (ii) hands-on-training and (iii) post-training evaluation and feedback. The Train-the-leaders course will be run in polish by the team from the Maria Sklodowska-Curie Memorial Cancer Center and Institute on Oncology, Warsaw, which was trained in delivering such intervention by experts from the United Kingdom.

Train the leaders course

Screening centre leaders randomized to the feedback group will receive (by e-mail and conventional mail) feedback on their individual screening colonoscopy quality indicators (adenoma detection rate and ceacal intubation rate) measured for the 2011 edition of the national screening program. The results will be presented in a league table in order to enable comparison with anonymous results of all endoscopists who performed at least 30 colonoscopies within the screening program. In addition, a link to a webpage containing data on individual and overall colonoscopy quality indicators over the last four years of the screening program will be provided.

Audit and feedback

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • screening center leading colonoscopist
  • at least 30 screening colonoscopies in the 2011 edition of the screening program
  • adenoma detection rate lower than 25%

You may not qualify if:

  • lack of participation in the 2012 edition of the screening program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology

Warsaw, 02-781, Poland

Location

Related Publications (1)

  • Kaminski MF, Anderson J, Valori R, Kraszewska E, Rupinski M, Pachlewski J, Wronska E, Bretthauer M, Thomas-Gibson S, Kuipers EJ, Regula J. Leadership training to improve adenoma detection rate in screening colonoscopy: a randomised trial. Gut. 2016 Apr;65(4):616-24. doi: 10.1136/gutjnl-2014-307503. Epub 2015 Feb 10.

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Michal F. Kaminski, MD, PhD

    The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology

    PRINCIPAL INVESTIGATOR
  • Jaroslaw Regula, MD, PhD

    The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2012

First Posted

August 17, 2012

Study Start

July 1, 2012

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

April 16, 2014

Record last verified: 2014-04

Locations